Guerbet

Pharmaceuticals, Biotechnology and Life Sciences

Targets setWell-below 2°C

SBTI ID

40003130

Informations générales

Localisation

France

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

20/04/2023

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2032

Statut

Targets set

Classification

Well-below 2°C

Année cible

2032

Progression vers l'objectif65%
2015 (année de référence)2032
Description complète des objectifs

Guerbet commits to reduce absolute scope 1 and 2 GHG emissions 27.5% by 2032 from a 2021 base year. Guerbet also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy activities, upstream transportation and distribution, waste generated in operations and downstream transportation and distribution 13.5% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to Well-below 2°C

Identifiants

ISIN

FR0000032526

LEI

969500WV1U1WQ059L135

Source : Science Based Targets initiative | Données publiques